3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Leukemia
19
Leukemia, Myelomonocytic, Acute
11
Leukemia, Monocytic, Acute
10
Leukemia, Erythroblastic, Acute
9
Congenital Abnormalities
8
Leukemia, Megakaryoblastic, Acute
7
Burkitt Lymphoma
6
Myelodysplastic Syndromes
4
Leukemia, Eosinophilic, Acute
4
Myeloproliferative Disorders
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Leukemia, Basophilic, Acute
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Hematologic Neoplasms
2
Thrombocytopenia
1
Thrombocythemia, Essential
1
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoproliferative Disorders
1
Interventions
fludarabine phosphate
12
Mycophenolic Acid
12
Cyclophosphamide
11
Whole-Body Irradiation
10
Cyclosporine
10
Cord Blood Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
7
Busulfan
6
Tacrolimus
5
Radiotherapy
5
fludarabine
4
Antilymphocyte Serum
4
Thiotepa
3
Methotrexate
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Cyclosporins
3
sargramostim
2
merphos
2
Methylprednisolone
2
Decitabine
2
Cytarabine
2
vatalanib
1
poly ICLC
1
lintuzumab
1
entinostat
1
Vorinostat
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory
×
Daunorubicin
×
Clear all
No trials found.